Prof. Dr. Karl-Peter Hopfner 

  •                                 
    Extbase Variable Dump
    'distribution:BiomSpeaker.html' (29 chars)
    
                            
  •                                     
    Extbase Variable Dump
    'fileadmin/Webdata/digimed/Symposium_2024/Fotos/Mike_Mendelson_300x300.jpg' (73 chars)
    
                                
  •                                     
    Extbase Variable Dump
    'Dr. med. Mike Mendelson' (23 chars)
    
                                
  •                                     
    Extbase Variable Dump
    'Director, Cardiovascular & Metabolism, Translational Medicine, Novartis Biom
     edical Research    ' (91 chars)
    
                                
  •                                     
    Extbase Variable Dump
    'Dr. Mike Mendelson joined the Novartis Institutes for Biomedical Research (N
     IBR) in 2019, leading early clinical development programs in arrhythmia and 
     cardiovascular rare disease indications. He is currently the cardio-immunolo
     gy early clinical development program lead. Prior to joining Novartis, he wa
     s a cardiologist at Boston Children's Hospital with a clinical focus in pedi
     atric preventive cardiology and a research focus in population genomics. He 
     completed research training with the U.S. NIH/NHLBI, Boston University, and 
     Harvard School of Public Health and clinical training at Boston Children’s H
     ospital/Harvard Medical School, SickKids Hospital/University of Toronto, and
      Montreal Children’s Hospital/McGill University.    ' (732 chars)